Related Experiment Video
Updated: May 31, 2026
08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
[Tuberculosis in Switzerland].
Otto Brändli1, Jean Pierre Zellweger
1Kompetenzzentrum Tuberkulose, Lungenliga Schweiz, Bern.
Therapeutische Umschau. Revue Therapeutique
|July 6, 2011
Summary
Tuberculosis (TB) is rare in Switzerland but cases rose unexpectedly between 2007-2009. Multidrug-resistant TB and late diagnoses pose significant public health challenges.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Context:
- Tuberculosis (TB) incidence in Switzerland is low overall, yet higher among specific demographics, particularly migrants.
- A recent increase in TB cases from 2007 to 2009, following a long-term decline, warrants investigation.
- The emergence of multidrug-resistant tuberculosis (MDR-TB) and challenges in timely diagnosis present significant hurdles.
Purpose:
- To analyze the current epidemiology of tuberculosis in Switzerland.
- To identify contributing factors to the recent increase in TB cases.
- To highlight the challenges posed by MDR-TB and diagnostic delays.
Summary:
- Switzerland has a low TB rate (2.8/100,000), but cases rose from 478 to 556 between 2007-2009.
- Multidrug-resistant TB accounts for 1.4% of cases, and late diagnosis is common.
- Public health initiatives include contact tracing, therapy, a "TB Manual," and a TB Hotline.
Impact:
- Informs public health strategies for TB control in Switzerland.
- Highlights the need for targeted interventions for high-risk populations.
- Emphasizes the importance of early diagnosis and treatment adherence for combating TB and MDR-TB.
Related Concept Videos
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...